Issue of Options

27 Dec 2007 10:02

Immunodiagnostic Systems Hldgs PLC27 December 2007 Immunodiagnostic Systems Holdings plc ("Immunodiagnostic " or "the Company") Issue of Options The Board of Immunodiagnostic announces that on 3 September 2007, options weregranted to Dr. Martha Louise Garrity to subscribe for an aggregate of 132,377ordinary shares of 2p each in the capital of the Company (the "Shares").Details of the options that have been granted are as follows: Options over 41,407 Shares exercisable at 241.5p per Share (granted under theImmunodiagnostic Systems Holdings plc Enterprise Management Initiative ShareOption Scheme). Options over 90,970 Shares exercisable at 241.5p per Share (granted asunapproved options under an option agreement). The exercise of options granted is subject to the achievement of certainperformance conditions set by the board, further details of which are providedon Page 50 of the 2007 Annual Report. For further information please contact: Immunodiagnostic Systems Holdings plc Tel: 0191 519 0660Dr. Roger DugganMr. Paul Hailes Oriel Securities Limited (Nominated Adviser) Tel: 020 7710 7600Andrew Edwards This information is provided by RNS The company news service from the London Stock Exchange